Activating pyruvate kinase R
US11071725B2 · kind B2 · utility
6Cited by
67References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 1, 2020 |
| Grant date | Jul 27, 2021 |
| Priority date | — |
| Expiry date | May 1, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D491/056
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This disclosure provides compounds and compositions for activating pyruvate kinase R (PKR) and related methods of manufacturing and using these compounds and compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.